Episode #65 - Interesting perspectives from Microsoft
Listen now
Description
Interesting perspectives from Microsoft
More Episodes
Clarity Pharmaceuticals Success: Clarity Pharmaceuticals reported a significant response in a patient with metastatic castrate-resistant prostate cancer. The patient received two cycles of copper 67 Biss. PSMA, and after six months from the second dose, there was no evidence of PSA,...
Published 05/01/24
Published 05/01/24
Episode #66: A crack in the semi facade? Angus Walker joins us
Published 04/19/24